Your search returned 47 results.

Results
	1.	Discontinued drugs in 2005: oncology drugs. [electronic resource] by Kelland, Lloyd Producer: 20061019 In: Expert opinion on investigational drugs vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The resurgence of platinum-based cancer chemotherapy. [electronic resource] by Kelland, Lloyd Producer: 20071001 In: Nature reviews. Cancer vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin. [electronic resource] by Kelland, Lloyd Producer: 20070723 In: Expert opinion on investigational drugs vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	EuroTIDES 2005--Sixth Annual IBC Conference. [electronic resource] by Kelland, Lloyd Producer: 20060324 In: IDrugs : the investigational drugs journal vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	5.	Drug evaluation: ADH-1, an N-cadherin antagonist targeting cancer vascularization. [electronic resource] by Kelland, Lloyd Producer: 20070405 In: Current opinion in molecular therapeutics vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	6.	Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. [electronic resource] by Kelland, Lloyd Producer: 20070925 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Emerging drugs for ovarian cancer. [electronic resource] by Kelland, Lloyd R Producer: 20060414 In: Expert opinion on emerging drugs vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	A new resistance mechanism to cisplatin? [electronic resource] by Kelland, Lloyd R Publication details: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy Jun 2000 In: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. [electronic resource] by Kelland, Lloyd R Producer: 20050621 In: European journal of cancer (Oxford, England : 1990) vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Farnesyl transferase inhibitors in the treatment of breast cancer. [electronic resource] by Kelland, Lloyd R Producer: 20030825 In: Expert opinion on investigational drugs vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Discovery and development of anticancer aptamers. [electronic resource] by Ireson, Christopher R Kelland, Lloyd R Producer: 20070607 In: Molecular cancer therapeutics vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Bioreductive prodrugs for cancer therapy. [electronic resource] by Seddon, Beatrice Kelland, Lloyd R Workman, Paul Producer: 20040301 In: Methods in molecular medicine vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	An expeditious synthesis of cytotoxic pyrroloisoquinoline derivatives. Structure-activity comparative studies with isomeric pyrroloquinolines. [electronic resource] by Vlachou, Margarita Tsotinis, Andrew Kelland, Lloyd R Thurston, David E Producer: 20030506 In: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor. [electronic resource] by Incles, Christopher M Schultes, Christoph M Kelland, Lloyd R Neidle, Stephen Producer: 20031125 In: Molecular pharmacology vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). [electronic resource] by Zhao, Liangli Marshall, Elaine S Kelland, Lloyd R Baguley, Bruce C Producer: 20070730 In: Investigational new drugs vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Synthesis and antimelanoma activity of sterically congested tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol. [electronic resource] by Ferguson, Jillian Rogers, Paul M Kelland, Lloyd R Robins, David J Producer: 20051018 In: Oncology research vol. 15 Availability: No items available. Save to lists Add to cart (remove)
	17.	Synthesis and biological evaluation of an N10-Psec substituted pyrrolo[2,1-c][1,4]benzodiazepine prodrug. [electronic resource] by Berry, Jane M Howard, Philip W Kelland, Lloyd R Thurston, David E Producer: 20020917 In: Bioorganic & medicinal chemistry letters vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Establishment and characterization of acquired resistance to the farnesyl protein transferase inhibitor R115777 in a human colon cancer cell line. [electronic resource] by Smith, Victoria Rowlands, Martin G Barrie, Elaine Workman, Paul Kelland, Lloyd R Producer: 20021227 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 8 Availability: No items available. Save to lists Add to cart (remove)
	19.	ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin. [electronic resource] by Smith, Vicki Hobbs, Stephen Court, William Eccles, Suzanne Workman, Paul Kelland, Lloyd R Producer: 20020913 In: Anticancer research vol. 22 Availability: No items available. Save to lists Add to cart (remove)
	20.	Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Increased tumor vascular permeability. [electronic resource] by Zhao, Liangli Ching, Lai-Ming Kestell, Philip Kelland, Lloyd R Baguley, Bruce C Producer: 20050802 In: International journal of cancer vol. 116 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 47 results.